This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Other. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Yani Chen: Innovator in Glucose Transport Modulation
Introduction
Yani Chen is an accomplished inventor based in Aurora, CA. He has made significant contributions to the field of biomedical engineering, particularly in the modulation of glucose transport. His innovative approach has the potential to impact various health conditions related to energy metabolism.
Latest Patents
Yani Chen holds a patent for a method titled "Method for modulating insulin-independent glucose transport using teneurin C-terminal associated peptide (TCAP)." This invention relates to a method of increasing energy available to skeletal muscle cells by administering an effective amount of Tenurin C-terminal Associated Peptide (TCAP). The invention provides the use of TCAP to enhance muscle performance or recovery after injury, as well as to prevent and/or treat conditions including insulin resistance, type II diabetes, hypoxia, and glycogen storage diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Yani Chen has demonstrated a commitment to advancing medical science through his research and inventions. His work has garnered attention for its potential applications in improving health outcomes for individuals suffering from metabolic disorders.
Collaborations
Yani Chen has collaborated with David Lovejoy, contributing to the development and refinement of his innovative methods. Their partnership has been instrumental in bringing new ideas to fruition in the field of glucose transport modulation.
Conclusion
Yani Chen's contributions to the field of glucose transport modulation highlight his innovative spirit and dedication to improving health outcomes. His work continues to inspire advancements in medical science and offers hope for those affected by metabolic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile